Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020
Cornelia Adlhoch(European Centre for Disease Prevention and Control), Sonja J. Olsen(National Influenza Center), Mia Brytting, Pavel Slezák(National Institute of Public Health), Concepción Delgado‐Sanz(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Isabelle Thomas(UCLouvain), Nathalie Bossuyt(Sciensano (Belgium)), Jackie Maistre Melillo(Ministry for Health), Odette Popovici(National Institute of Public Health), Sierk Marbus(Leiden University Medical Center), Tanya Melillo(Ministry for Health), Monika Redlberger‐Fritz(Medical University of Vienna), Joana Gomes Dias(European Centre for Disease Prevention and Control), Raquel Guiomar, Joan O’Donnell(Health Service Executive), AnnaSara Carnahan(Swedish Institute), Arianne B. van Gageldonk‐Lafeber(National Institute for Public Health and the Environment), Lisa Domegan(Health Service Executive)
Cited by 14
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009
|New England Journal of Medicine|2009|1.7k
H1N1 2009 influenza virus infection during pregnancy in the USA
|The Lancet|2009|1.4k
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
|The Lancet|2011|999
Transmission of the Severe Acute Respiratory Syndrome on Aircraft
|New England Journal of Medicine|2003|737